Provided by Tiger Trade Technology Pte. Ltd.

Fennec Pharmaceuticals Inc.

11.40
+0.11000.97%
Volume:218.90K
Turnover:2.48M
Market Cap:399.77M
PE:-95
High:11.47
Open:11.29
Low:10.88
Close:11.29
52wk High:13.25
52wk Low:5.65
Shares:35.07M
Float Shares:19.78M
Volume Ratio:1.16
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1200
EPS(LYR):-0.3409
ROE:-18.58%
ROA:-1.16%
PB:9.42
PE(LYR):-33.44

Loading ...

Apr 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 27, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 24, 2026

Major Issues Report

Form 8-K - Current report
Mar 16, 2026

Major Issues Report

Form 8-K - Current report
Mar 06, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 04, 2026

Major Issues Report

Form 8-K - Current report
Mar 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 20, 2026

Major Issues Report

Form 8-K - Current report
Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 09, 2025

Major Issues Report

Form 8-K - Current report
Dec 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 02, 2025

Major Issues Report

Form 8-K - Current report
Nov 19, 2025

Major Issues Report

Form 8-K - Current report
Nov 19, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 19, 2025

Major Issues Report

Form 8-K - Current report
Nov 17, 2025

Major Issues Report

Form 8-K - Current report
Nov 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities